CA-GUESS?
27.7.2022 17:02:14 CEST | Business Wire | Press release
In collaboration with Homeboy Industries, GUESS has developed a unique process to give new life to old clothing. By transforming recycled pieces into fun, fashionable creations, GUESS is building a new pathway to being fabulously sustainable. Sustainability is at the heart of all that GUESS does, and the Company’s partnership with the non‐profit Homeboy Industries represents this commitment.
GUESS will work directly with Homeboy Recycling, a social enterprise branch of Homeboy Industries on the new Upcycled Collection. In partnering with GUESS, Homeboy Recycling has expanded from exclusively electronics recycling into the world of textiles and apparel. GUESS and Homeboy Recycling have created not only a remarkable new line of goods and apparel, but a new way to support environmental sustainability, facilitate creativity, create new jobs, and uplift our community: upcycled with a whole lot of heart.
It is with absolute pride that GUESS announces the Upcycled Collection. A collection unlike any other, because no two pieces are alike. Transforming recycled clothing yields distinctly unique pieces, and that is its ultimate appeal. Tote bags, patchwork denim, bustiers, and even throw pillows; upcycled fashion for everyone. The Upcycled Collection is a sustainable, fashionable, purposeful way to shop‐the truest form of circular fashion.
“Homeboy Industries is grateful for the partnership with GUESS for the Upcycled Collection. We thank GUESS for supporting our mission to provide hope, training, and support to this marginalized population, allowing them to change the arc of their lives and become contributing members of the community. Homeboy Industries provides comprehensive trauma‐informed, wrap‐around support services such as tattoo removal, mental health services, education, legal, housing navigation, case management, workforce development, and job training,” says Chris Zwicke, CEO of Homeboy Industries. “Through this partnership, our employees at our fastest growing social enterprise, Homeboy Recycling, will gain more job skills and training, which we are very excited about.”
“The Upcycled Collection in collaboration with Homeboy Industries is designed with the hope that each piece can give purpose to a member of the community who can learn the skills needed to turn discarded merchandise into desirable, commodified items with an eye to the fashion set. The designs are determined by the resources at hand, which are carefully organized and sorted. The product range is fashion to non‐fashion pieces, so there is something for everyone. And the true joy is the wonderment around the former life of each piece and how it came to be,” says Amy Enuke, Young Contemporary Design Director.
With GUESS’ commitment to circular fashion and Homeboy Recycling’s foundation of sustainability, this partnership is the launching pad for a new kind of sustainable fashion—one that not only supports the environment but also directly supports our communities. To learn more about GUESS’ commitment to our planet, visit guess.com/sustainability
About GUESS?, Inc.
Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand. Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. As of April 30, 2022, the Company directly operated 1,073 retail stores in the Americas, Europe and Asia. The Company’s partners and distributors operated 565 additional retail stores worldwide. As of April 30, 2022, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com.
About Homeboy Recycling
Homeboy Recycling is a certified and award-winning social enterprise offering nationwide services for the proper disposal and management of IT assets. As one of the few R2 (Responsible Recycling) and B Corp certified companies in the world, Homeboy is committed to the highest possible standards for electronics reuse, e-waste recycling and the destruction of sensitive data. Each year, Homeboy refurbishes thousands of computers and diverts millions of pounds of electronics away from the landfill while creating jobs for people facing systemic barriers to employment. Beyond our IT asset disposition and e-waste services, we see ourselves broadly as a partner in the circular economy. We work with committed manufacturers and brands to develop socially and environmentally beneficial solutions for their products after their first life. In this capacity, we are expanding our services to include apparel/textiles and other products/materials that fit our mission.
As part of Homeboy Industries, the world’s preeminent gang rehabilitation and re-entry program, Homeboy Recycling proudly employs people committed to transforming their lives after incarceration. For more information, visit https://homeboyrecycling.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005664/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom